Quantum Biopharma Ltd Cls B Subordinate Voting S(QNTM-CN)CSE
Today's Change
Delayed Last Update
Pre Market Change
Pre Market Last Update
Volume
Latest News
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
ACCESSWIRE - Tue Oct 22, 2:00AM CDT
ACCESSWIRE
Tue Oct 22, 2:00AM CDT
To assist enquiries the copy of the complaint can be viewed by clicking the following link: Quantum Bio Pharma Complaint
Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
Newsfile - Mon Oct 21, 8:34AM CDT
Newsfile
Mon Oct 21, 8:34AM CDT
Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused substantial damages to the Company and its shareholdersToronto, Ontario--(Newsfile Corp. - October 21, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE:...
Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America
Newsfile - Mon Oct 7, 7:44AM CDT
Newsfile
Mon Oct 7, 7:44AM CDT
Toronto, Ontario--(Newsfile Corp. - October 7, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma") provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu" or the "Company"), and its launching of unbuzzd™, an innovative beverage product that is scientifically...
Quantum BioPharma Closes Private Placement Offering
Newsfile - Fri Sep 13, 7:14PM CDT
Newsfile
Fri Sep 13, 7:14PM CDT
Toronto, Ontario--(Newsfile Corp. - September 13, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K9) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that, further to its press release dated September 6, 2024 (the "September 6th...
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis
ACCESSWIRE - Mon Sep 9, 2:30AM CDT
ACCESSWIRE
Mon Sep 9, 2:30AM CDT
TORONTO, ON / ACCESSWIRE / September 9, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech...
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM"
Newsfile - Thu Aug 15, 5:02AM CDT
Newsfile
Thu Aug 15, 5:02AM CDT
Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) ("Quantum BioPharma" or the "Company"), formerly FSD Pharma Inc., a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that, further to its press release dated August...